These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1802483

  • 1. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
    Maruyama T, Watanabe K, Yanagawa T, Kasatani T, Kasuga A, Shimada A, Takei I, Suzuki Y, Kataoka K, Saruta T.
    Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
    [Abstract] [Full Text] [Related]

  • 2. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice.
    Maruyama T, Watanabe K, Takei I, Kasuga A, Shimada A, Yanagawa T, Kasatani T, Suzuki Y, Kataoka K, Saruta.
    Diabetes Res; 1991 May; 17(1):37-41. PubMed ID: 1823558
    [Abstract] [Full Text] [Related]

  • 3. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T, Sato S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [Abstract] [Full Text] [Related]

  • 4. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M, Saijo N, Ozaki A, Beppu Y, Shimizu E, Takizawa T, Hoshi A.
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
    [Abstract] [Full Text] [Related]

  • 5. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S, Naruo K, Ootsu K, Houkan T, Shiho O, Tsukamoto K.
    Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
    [Abstract] [Full Text] [Related]

  • 6. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
    De Ruysscher D, Sobis H, Vandeputte M, Waer M.
    J Immunol; 1991 Jun 15; 146(12):4065-70. PubMed ID: 1828259
    [Abstract] [Full Text] [Related]

  • 7. Expression of asialo GM1 by both Thy-1-positive and Thy-1-negative lymphocytes: evidence for modification of asialo GM1 by sialic acid.
    Harris MT, Schwarting GA, Stout RD.
    Thymus; 1981 Sep 15; 3(3):169-84. PubMed ID: 6171919
    [Abstract] [Full Text] [Related]

  • 8. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H, Yogeeswaran G, Bukowski JF, Welsh RM.
    Nat Immun Cell Growth Regul; 1985 Sep 15; 4(1):21-39. PubMed ID: 3875791
    [Abstract] [Full Text] [Related]

  • 9. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
    Suzuki S, Suzuki R, Onta T, Kumagai K.
    Nat Immun Cell Growth Regul; 1986 Sep 15; 5(2):75-89. PubMed ID: 3487716
    [Abstract] [Full Text] [Related]

  • 10. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes.
    Schultheis RJ, Kearns RJ.
    Nat Immun Cell Growth Regul; 1990 Sep 15; 9(6):376-86. PubMed ID: 2128370
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E.
    Cancer Res; 1987 Feb 01; 47(3):809-15. PubMed ID: 3802083
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
    Suttles J, Schwarting GA, Stout RD.
    J Immunol; 1986 Mar 01; 136(5):1586-91. PubMed ID: 2936802
    [Abstract] [Full Text] [Related]

  • 13. A glycolipid on the surface of mouse natural killer cells.
    Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T.
    Eur J Immunol; 1980 Mar 01; 10(3):175-80. PubMed ID: 6966574
    [Abstract] [Full Text] [Related]

  • 14. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 15. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM, Tang JC, DeLong DC, Ades EW, Altom MG.
    Cancer Res; 1986 Nov 15; 46(11):5624-8. PubMed ID: 3756909
    [Abstract] [Full Text] [Related]

  • 16. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A, Nestel FP, Seemayer TA, Lapp WS.
    J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120
    [Abstract] [Full Text] [Related]

  • 17. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 18. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
    Keller R, Bächi T, Okumura K.
    Exp Cell Biol; 1983 Mar 01; 51(3):158-64. PubMed ID: 6852344
    [Abstract] [Full Text] [Related]

  • 19. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C, Dennert G.
    J Immunol; 1988 Feb 01; 140(3):744-9. PubMed ID: 2448375
    [Abstract] [Full Text] [Related]

  • 20. Reduction of acute graft-versus-host disease-related mortality and cytotoxic T lymphocyte induction after pretreatment of the recipient with anti-asialo GM1 antibody in the murine P-to-F1 model.
    Varkila K, Hurme M.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 3):2690-1. PubMed ID: 3274580
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.